Lataa...
MERS-CoV spike protein: Targets for vaccines and therapeutics
The disease outbreak caused by Middle East respiratory syndrome coronavirus (MERS-CoV) is still ongoing in the Middle East. Over 1700 people have been infected since it was first reported in September 2012. Despite great efforts, licensed vaccines or therapeutics against MERS-CoV remain unavailable....
Tallennettuna:
| Julkaisussa: | Antiviral Res |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier B.V.
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7113765/ https://ncbi.nlm.nih.gov/pubmed/27468951 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2016.07.015 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|